Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anticaries Effect of Probiotic Lactobacillus Brevis CD2 (Lb CD2). A Randomized Double Blind Interventional Study.

NCT01778699 is registered in ClinicalTrials.gov with Università degli Studi di Sassari as lead sponsor.

NCT NCT01778699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01778699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anticaries Effect of Probiotic Lactobacillus Brevis CD2 (Lb CD2). A Randomized Double Blind Interventional Study.
Lead sponsor
Università degli Studi di Sassari
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2013
Completion date
April 30, 2015
Enrollment
440 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dental caries, gingivitis